Injectable Hydrogel Shows Promise in Rapidly Increasing Bone Density
Researchers at EPFL and Flowbone have developed a nanoparticle-based hydrogel that could enhance osteoporosis treatment by significantly boosting localized bone density within weeks.
- The injectable hydrogel, made from hyaluronic acid and hydroxyapatite nanoparticles, mimics natural bone minerals to promote rapid bone densification.
- In laboratory tests on rats, the hydrogel alone increased local bone density by two- to three-fold, with results seen in just 2-4 weeks.
- Combining the hydrogel with systemic osteoporosis drugs, such as Zoledronate, led to a 4.8-fold increase in bone density at injection sites.
- Current osteoporosis treatments often take up to a year to show results, leaving patients vulnerable to fractures; this hydrogel aims to address that gap by providing faster localized effects.
- The research team is awaiting regulatory approval to begin human trials, with hopes of demonstrating the hydrogel’s potential to prevent fractures and support implants in weakened bones.